Toward clinical understanding of aristolochic acid upper-tract urothelial carcinoma

被引:10
|
作者
Boot, Arnoud [1 ,2 ]
Jiang, Nanhai [1 ,2 ]
Rozen, Steven G. [1 ,2 ,3 ,4 ]
机构
[1] Duke NUS Med Sch, Duke NUS Ctr Computat Biol, 8 Coll Rd, Singapore 1698572, Singapore
[2] Duke NUS Med Sch, Signature Res Programme Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore
[3] SingHealth Duke NUS Inst Precis Med, 5 Hosp Dr, Singapore 169609, Singapore
[4] SingHealth Duke NUS Global Hlth Inst, 8 Coll Rd, Singapore 169857, Singapore
来源
THERANOSTICS | 2020年 / 10卷 / 12期
基金
英国医学研究理事会;
关键词
MUTATIONAL SIGNATURE; NEPHROPATHY; ETIOLOGY; CANCER;
D O I
10.7150/thno.46489
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A cluster of patients poisoned by herbal medicine in the 1990s revealed that aristolochic acid (AA) causes kidney failure and upper tract urothelial carcinoma (UTUC). Recent research demonstrated that this was not an isolated incident; on the contrary, AA exposure is widespread in East Asia. This editorial highlights research by Lu and colleagues that investigates clinical characteristics of AA and non-AA UTUCs from 90 patients in Beijing based on the AA mutational signature. The study also detected AA mutations in non-tumor tissue of AA exposed patients and showed that AA mutations can be detected in urine, which might form the basis for non-invasive tests for AA exposure.
引用
收藏
页码:5578 / 5580
页数:3
相关论文
共 50 条
  • [1] Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
    Colin, Pierre
    Seisen, Thomas
    Mathieu, Romain
    Shariat, Sharohkh F.
    Roupret, Morgan
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2016, 5 (05) : 648 - 654
  • [2] Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
    Petros, Firas G.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (04) : 1794 - 1798
  • [3] Endoscopic management of upper-tract urothelial carcinoma
    Raman, Jay D.
    Park, Rosa
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (06) : 545 - 554
  • [4] Risk Assessment of Upper Tract Urothelial Carcinoma Related to Aristolochic Acid
    Wu, Felicia
    Wang, Tianxiu
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (05) : 812 - 820
  • [5] Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
    Chen, Chung-Hsin
    Dickman, Kathleen G.
    Huang, Chao-Yuan
    Moriya, Masaaki
    Shun, Chia-Tung
    Tai, Huai-Ching
    Huang, Kuo-How
    Wang, Shuo-Meng
    Lee, Yuan-Ju
    Grollman, Arthur P.
    Pu, Yeong-Shiau
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (01) : 14 - 20
  • [6] Complex Percutaneous Resections for Upper-Tract Urothelial Carcinoma
    Irwin, Brian H.
    Berger, Andre K.
    Brandina, Ricardo
    Stein, Robert
    Desai, Mihir M.
    JOURNAL OF ENDOUROLOGY, 2010, 24 (03) : 367 - 370
  • [7] Kidney sparing surgery for upper-tract urothelial carcinoma
    Raman, Jay D.
    MINERVA UROLOGICA E NEFROLOGICA, 2016, 68 (04) : 359 - 371
  • [8] Clinical features and prognostic indicators in upper-tract urothelial carcinoma with bone metastasis
    Zhou, Mingping
    Zhang, Jianxin
    Chen, Xiaowei
    Wang, Zhan
    Liang, Wei
    FRONTIERS IN SURGERY, 2022, 9
  • [9] The Limited Value of Upper-Tract Urine Cytology for the Diagnosis of Upper Tract Urothelial Carcinoma
    Hayakawa, N.
    Kikuchi, E.
    Matsumoto, K.
    Kouno, H.
    Mizuno, R.
    Nagata, H.
    Asanuma, H.
    Miyajima, A.
    Nakagawa, K.
    Oya, M.
    UROLOGY, 2012, 80 (03) : S23 - S23
  • [10] Trends in the utilization of diagnositics for upper-tract urothelial carcinoma.
    Vemana, Goutham
    Bhayani, Sam
    Baty, Jack
    Vetter, Joel
    Strope, Seth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)